January 31, 2018 5:30pm
Sector intelligence and perspective
It's unreasonable to think the sector would recover quickly as the sector opened positive, was down at 11 a.m. with a negative mid-day that closed to the downside with an advance/decline line (A/DL) of 12/27 and 1 flat of the 40 covered;
The IBB (-1.88%), XBI (-1.75%), XLV (-1.42%), IWM (-0.48) dived again as the NASDAQ (+0.12%) was up and the VIX plunged -8.45%
Fundamentals are in play with heavy negative breadth and lower volume
Pre-open indications: 2 hits and 3 miss (1 by pennies)
Out and about: Gene therapy companies continued to dive after yesterday’s plunge due to possible risks of high systemic dosing of AAV – the players … AGTC (-$0.30), BOLD (-$2.19), ONCE (-$3.02), AVXS (-$0.46), ADVM (-$0.77), RGNX (-$1.40) and QURE (-$0.98) except for BLUE (+$0.85).
The Biostage (BSTG +$0.01) chronicles … don’t be fooled by surges of day trading after 20 M shares were reversed and past shareholders were “fleeced” in MY opinion!
Members only. Please login.
